WAM
DMAAR

Wolverine Asset Management’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Wolverine Asset Management’s Portfolio DMAAR Stock Details DMAAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.9K Sell
471,683
-221,453
-32% -$22.9K ﹤0.01% 1251
2026
Q1 		$41.9K Buy
693,136
+130,000
+23% +$13.8K ﹤0.01% 1278
2025
Q4 		$105K Sell
563,136
-2
-0% – ﹤0.01% 1178
2025
Q3 		$122K Sell
563,138
-37,900
-6% -$7.05K ﹤0.01% 1081
2025
Q2 		$72.2K Sell
601,038
-2,000
-0.3% -$257 ﹤0.01% 1172
2025
Q1 		$78.4K Buy
+603,038
New +$84.7K ﹤0.01% 1123

Other funds holding DMAAR

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Wolverine Asset Management's DMAAR Position: Q2 2026 in Review

Wolverine Asset Management reduced its Drugs Made In America Acquisition Corp Rights (DMAAR) stake by 32% in Q2 2026, selling an estimated $22.9K and leaving 471,683 shares worth $51.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1251.

Wolverine Asset Management first reported a position in DMAAR in Q1 2025 and has held it in 6 quarters since. The position peaked at $122K in Q3 2025. 28 funds tracked by Wall St. Rank hold DMAAR as of Q2 2026.

  • Wolverine Asset Management held 471,683 shares of Drugs Made In America Acquisition Corp Rights worth $51.9K as of Q2 2026.
  • Wolverine Asset Management sold 221,453 Drugs Made In America Acquisition Corp Rights shares in Q2 2026, an estimated $22.9K.
  • Drugs Made In America Acquisition Corp Rights made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1251 holding.
  • Wolverine Asset Management first reported a position in Drugs Made In America Acquisition Corp Rights in Q1 2025 and has held it in 6 quarters since.
  • Wolverine Asset Management's Drugs Made In America Acquisition Corp Rights position peaked at $122K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Rights as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.